2nd Life Sciences Investigations & Internal Audits Forum

Date: 14-May-15 to 15-May-15
Location: Wyndham Philadelphia Historic District / Philadelphia / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

International investigations under the FCPA are presenting investigators with new challenges, while in the United States the DOJ, SEC and FDA are turning their attention to monitoring the life sciences industry. The costs of a failed inspection can be devastating at worst and result in heavy fines and bad publicity at best.
After conducting a number of investigations, you understand the need to continuously improve this process. ExL Events’ 2nd Life Sciences Investigations & Internal Audits Forum will educate legal, compliance and HR/ER professionals on how to conduct an efficient and compliant internal investigation to ensure proper remediation and solve issues before they become problems. Come away with a tool kit of strategies for prevention, preparation and management. Implement a framework to encourage reporting, update monitoring points, detect off-label promotion, triage tips and assign leads, report to agencies, keep all cross-divisional players up to date, and take proper steps to remediation.

Exhibitors

Darshan Kulkarni - Principal - KULKARNI LLC, Deborah Penza - Chief Compliance Officer - ACTAVIS, Roseann Model - Corporate Compliance Officer - BIO-RAD LABORATORIES, Becky Armstrong - Compliance Investigator - HEALTH PARTNERS, Joseph Cacciatore - Executive Director Ethics & Compliance - NOVARTIS, Diana Roses - Quality Assurance Specialist III Investigations and CAPA - GENENTECH, Rahsaan Thompson - Associate General Counsel - ACTELION, Jane Wasman - President International and General Counsel - ACORDA THERAPEUTICS, Josh Axelrod - Compliance Counsel - JAZZ PHARMACEUTICALS, Arthur McCarthy - Senior Manager Compliance Investigations - NOVO NORDISK, Alexis Stroud - Associate Director Corporate Compliance - PURDUE PHARMA

Go to event website